Large Study of PrEP Use in Clinical Practice Shows No New HIV Infections

In one of the first and largest published evaluations of the use of Pre-exposure Prophylaxis (PrEP) to prevent HIV infection in a clinical practice setting, researchers at Kaiser Permanente found no new HIV infections among patients during more than 2.5 years of observation. The study was the first done outside of clinical trials and demonstration sites and suggests that PrEP may prevent new HIV infections in a high-risk setting. Read more about the study here.

About Alyssa Kitlas

Alyssa Kitlas serves as a Program Analyst on NACCHO's HIV, STI, and Viral Hepatitis team. Her work includes projects on HIV, STI, and Viral Hepatitis prevention and care. Twitter: @AlyssaKitlas

Leave a Reply

Your email address will not be published. Required fields are marked *